Regular weigh-ins can provide a clear picture of the patients progress towards weight loss goals and reveal changes in BMI over time
A typical reconstitution for a 5mg vial is 2mL of bacteriostatic water, yielding a working concentration of 2.5mg/mL
split larger volumes into separate injections [9]
In 2009, the first glucagon and GLP-1 receptor co-agonist was reported, which combined action profiles of two gastrointestinal hormones within a single molecule achieving a synergistic glucose-lowering and weight loss benefit
Xia, J., Psychogios, N., Young, N
Peter Attia, M.D., a Stanford and Johns Hopkins School of Medicine-trained physician expert in improving human healthspan and lifespan